Skip to main content

Table 3 Physicians’ barriers to treat hyperlipidemia among patients with rheumatoid arthritis with their respective priority votes

From: Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis

LevelSub-levelRheumatologist Votes (%)aPCP Votes (%)a
Physician LevelTotal Votes, %87.025.0
Conflict regarding ownership of hyperlipidemia management37.70.0
Lack of training and knowledge of hyperlipidemia guidelines32.118.3
Lack of time11.10.8
Focus only on RA6.2
Prioritize non-pharmacologic measures (diet and exercise)4.2
Difficulty implementing lifestyle modifications for patients with pain1.7
Patient LevelTotal Votes, %5.669.2
Side effects of statins2.542.5
Patient already on multiple medications2.58.3
Side effects of RA medications and RA drug interactions0.6
Comorbidities6.7
Complexity of RA and its treatment5.8
Patients’ lack of awareness of CVD risk1.7
Priority of RA symptomology over preventive measures4.2
System LevelTotal Votes, %7.4%5.8
Financial barriers (limited insurance coverage, cost of additional medications, cost of repeating labs)6.2%0.0
Limited clinic staff support1.2%
Lack of care coordination5.8
  1. RA Rheumatoid arthritis, CVD Cardiovascular disease. 0% = that sub-level emerged during the brainstorming session but did not receive votes. “--” = the sub-level did not emerge in the respective group
  2. aTotal votes are calculated based on the number of participating physicians. Each physician had a total of 6 votes (3 for the most important, 2 votes for the second most important, and 1 for the third most important statement). Hence, 27 rheumatologist participated × 6 votes each = 162 votes; 20 PCPs participated × 6 votes = 120 votes